Summary

Market Overview
The Global Maternal Mental Health Market is anticipated to expand from USD 5.97 billion in 2025 to USD 10.57 billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.99%. This market includes a wide variety of diagnostics, treatments, and support services designed to prevent, detect, and manage mental health issues throughout pregnancy and the postpartum phase. Growth is primarily fueled by rising awareness of perinatal mental health among the public and healthcare professionals, deeper recognition of how maternal health affects child development, and the increasing worldwide incidence of postpartum depression and anxiety. For context, the World Health Organization reported in 2023 that about 10% of expectant mothers and 13% of recent mothers worldwide suffer from a mental health condition, with depression being the most common.
A major hurdle that may slow market expansion is the ongoing worldwide shortage of dedicated maternal mental health experts, especially in disadvantaged areas. This deficit in skilled personnel limits patients' ability to receive prompt and suitable treatment, which could in turn hinder the widespread rollout and utilization of essential mental health services and interventions.
Market Driver
State funding and favorable regulations are strongly driving the global maternal mental health market by building specific infrastructure and increasing access to services. These public sector efforts frequently result in direct financial support, which facilitates the growth of crucial treatment networks. For example, the Royal College of Midwives noted that in February 2025, ?36.5 million was designated to enhance family mental health support in England, originating from a broader ?126 million state funding increase for the 2025?2026 period. These investments enable the creation and expansion of specialized perinatal mental health programs, professional training, and routine screening initiatives. Furthermore, policies stimulate market advancement by requiring insurance benefits and encouraging integrated care frameworks, ensuring that maternal mental health is treated as a standard, reimbursable element of comprehensive maternity care.
Progress in digital and telehealth solutions acts as another powerful growth catalyst by revolutionizing access to maternal mental health care, especially in remote or disadvantaged regions. Technological breakthroughs like mobile apps, online counseling platforms, and remote patient monitoring tackle geographic limitations and staff shortages directly, facilitating quicker assistance. Highlighting this trend, Startup Nation Central's "2026 Mental Health Technology Map" from January 2026 revealed that funding for the general mental health tech industry reached $352 million in 2025?a 150% jump from the prior year?signaling intensified interest in scalable models suitable for maternal care. This capital surge aids the creation of accessible, efficient digital tools that improve patient convenience and lower stigma through private care options. This technological evolution is vital given that untreated maternal mental health issues cost the Canadian economy an estimated $11 billion annually, as reported during Benefits Canada's 2025 Mental Health Summit in August 2025.
Market Challenge
The ongoing worldwide deficit of dedicated maternal mental health specialists stands as a major obstacle to the expansion of the global maternal mental health market. This lack of personnel directly curtails access to prompt and proper treatment, thereby stunting the broader implementation and growth of vital diagnostics, therapies, and support systems. Market progress is ultimately slowed because a large segment of the target demographic is unable to easily access these much-needed services due to an inadequate supply of trained professionals.
These human resource constraints lead to massive gaps in care delivery. As highlighted by the Policy Center for Maternal Mental Health in 2025, 84% of the perinatal demographic in the United States lived in regions experiencing a shortage of maternal mental health providers. Such pervasive scarcities emphasize that a lack of available specialists directly suppresses market reach and care execution, consequently limiting the revenue prospects and the distribution of essential treatments meant to combat perinatal mental health conditions.
Market Trends
The rise and integration of digital therapeutics (DTx) are heavily shaping the global maternal mental health market by providing expandable, scientifically backed treatments. These software-based tools deliver structured therapy for issues such as postpartum depression, greatly improving access for patients who encounter obstacles to conventional in-person care. This market momentum is further accelerated by favorable regulatory frameworks and the establishment of transparent payment channels. For instance, a December 2024 publication titled "Are Maternal Mental Health Digital Therapeutics Ready for Prime Time?" noted that the Centers for Medicare and Medicaid Services (CMS) rolled out three new Healthcare Common Procedure Coding System billing codes in its Proposed 2025 Medicare Physician Fee Schedule. Taking effect on January 1, 2025, these codes are tailored for FDA-approved digital mental health devices, creating a reimbursement structure that promotes wider industry acceptance.
Another crucial trend transforming the maternal mental health market is the growing incorporation of behavioral health services directly into obstetrics. By embedding mental health screenings, evaluations, and treatments into routine prenatal and postpartum visits, this strategy promotes much earlier identification and care. This seamless integration combats fragmented healthcare and lowers barriers to entry, ensuring that mental health support becomes a standard part of overall maternal treatment. The Policy Center for Maternal Mental Health's "2025 Impact Report," published in January 2026, highlighted this shift by analyzing 41 state Medicaid Managed Care Organization contracts; it found that nine states currently mandate or reward obstetricians for managing maternal mental health via screenings, financial incentives, or HEDIS? reporting. This demonstrates an early yet accelerating regulatory movement favoring holistic, unified care frameworks.

Key Market Players
* Therapy Mama
* Canopie Inc
* Pfizer Inc
* Viatris Inc.
* GSK plc
* Alembic Pharmaceuticals Limited
* Keenova Therapeutics plc
* Saphire, Inc.
* Bausch Health Companies Inc.
* Magellan Health, Inc.

Report Scope
In this report, the Global Maternal Mental Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

# Maternal Mental Health Market, By Disease Indication
* Postpartum Depression
* Dysthymia
* Pregnancy and Postpartum General Anxiety
* Pregnancy and Postpartum OCD
* Birth-Related PTSD
* Others
# Maternal Mental Health Market, By Therapy
* Interpersonal Psychotherapy
* Antidepressants
* Cognitive Behavioral Therapy
* others
# Maternal Mental Health Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Maternal Mental Health Market.
Available Customizations:
Global Maternal Mental Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Maternal Mental Health Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others)
5.2.2. By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others)
5.2.3. By Region
5.2.4. By Company (2025)
5.3. Market Map
6. North America Maternal Mental Health Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Indication
6.2.2. By Therapy
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Maternal Mental Health Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Disease Indication
6.3.1.2.2. By Therapy
6.3.2. Canada Maternal Mental Health Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Disease Indication
6.3.2.2.2. By Therapy
6.3.3. Mexico Maternal Mental Health Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Disease Indication
6.3.3.2.2. By Therapy
7. Europe Maternal Mental Health Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Disease Indication
7.2.2. By Therapy
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Maternal Mental Health Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Disease Indication
7.3.1.2.2. By Therapy
7.3.2. France Maternal Mental Health Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Disease Indication
7.3.2.2.2. By Therapy
7.3.3. United Kingdom Maternal Mental Health Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Disease Indication
7.3.3.2.2. By Therapy
7.3.4. Italy Maternal Mental Health Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Disease Indication
7.3.4.2.2. By Therapy
7.3.5. Spain Maternal Mental Health Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Disease Indication
7.3.5.2.2. By Therapy
8. Asia Pacific Maternal Mental Health Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Indication
8.2.2. By Therapy
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Maternal Mental Health Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Disease Indication
8.3.1.2.2. By Therapy
8.3.2. India Maternal Mental Health Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Disease Indication
8.3.2.2.2. By Therapy
8.3.3. Japan Maternal Mental Health Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Disease Indication
8.3.3.2.2. By Therapy
8.3.4. South Korea Maternal Mental Health Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Disease Indication
8.3.4.2.2. By Therapy
8.3.5. Australia Maternal Mental Health Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Disease Indication
8.3.5.2.2. By Therapy
9. Middle East & Africa Maternal Mental Health Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Disease Indication
9.2.2. By Therapy
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Maternal Mental Health Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Disease Indication
9.3.1.2.2. By Therapy
9.3.2. UAE Maternal Mental Health Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Disease Indication
9.3.2.2.2. By Therapy
9.3.3. South Africa Maternal Mental Health Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Disease Indication
9.3.3.2.2. By Therapy
10. South America Maternal Mental Health Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Disease Indication
10.2.2. By Therapy
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Maternal Mental Health Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Disease Indication
10.3.1.2.2. By Therapy
10.3.2. Colombia Maternal Mental Health Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Disease Indication
10.3.2.2.2. By Therapy
10.3.3. Argentina Maternal Mental Health Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Disease Indication
10.3.3.2.2. By Therapy
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Maternal Mental Health Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Therapy Mama
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Canopie Inc
15.3. Pfizer Inc
15.4. Viatris Inc.
15.5. GSK plc
15.6. Alembic Pharmaceuticals Limited
15.7. Keenova Therapeutics plc
15.8. Saphire, Inc.
15.9. Bausch Health Companies Inc.
15.10. Magellan Health, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer